Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neurocrine Bioscience buy Guggenheim

Start price
€131.25
02.05.24 / 50%
Target price
€158.42
02.05.25
Performance (%)
-1.33%
Price
€129.50
10:59
Summary
This prediction is currently active. With a performance of -1.33%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 02.05.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w
Neurocrine Bioscience 0.577%
iShares Core DAX® -0.051%
iShares Nasdaq 100 1.659%
iShares Nikkei 225® 0.658%
iShares S&P 500 0.964%

Comments by Guggenheim for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) -1.33%
Target price 158.423
Change
Ends at 02.05.25

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Guggenheim from $164.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat